Promising Objective Response Rates and Progression-Free Survival but Modest Overall Survival in the TAB Study.
Naohiro OkanoTomonori MizutaniShuichi HironakaPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Keyphrases